Certified by Founder Lodge
BrightEdge - American Cancer Society
United States - Atlanta, Georgia
INVESTOR
1 Disclosed Funding Rounds $41,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BrightEdge is the American Cancer Society’s impact investment arm that, through equity investment seeks to translate groundbreaking cancer research into commercially accessible solutions, dee
| Company | Date | Round | Raised |
|---|---|---|---|
 Mercy BioAnalytics, Inc. |
April, 04 ,2023 | Series A | $41,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Axiomatic_AI | $18,000,000 | (Mar 10, 2026)
KAST | $80,000,000 | (Mar 10, 2026)
Advocacy | $3,500,000 | (Mar 10, 2026)
ANEUVO | $22,000,000 | (Mar 10, 2026)
Mirai Robotics | $4,200,000 | (Mar 10, 2026)
